PlainRecalls
FDA Drug Critical Class I Terminated

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Reported: April 30, 2014 Initiated: March 14, 2014 #D-1251-2014

Product Description

VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.

Reason for Recall

Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.

Details

Units Affected
8359 vials
Distribution
US Nationwide including Puerto Rico; Mexico, Columbia
Location
Lexington, MA

Frequently Asked Questions

What product was recalled?
VPRIV¿ (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human Genetic Therapies, Inc. 300 Shire Way, Lexington, MA 02421. NDC: 54092-701-04.. Recalled by Shire Human Genetic Therapies, Inc.. Units affected: 8359 vials.
Why was this product recalled?
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 30, 2014. Severity: Critical. Recall number: D-1251-2014.